foghorn therapeutics logo

Foghorn Therapeutics

Foghorn Therapeutics Inc. develops gene controlling therapies. It owns and operates Gene Traffic Control, a platform that directs which genes cells express, and when, where, and in what order.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://foghorntx.com
Founded2016
Disease Focus
Development Stage
STOCK CODENon Listed
Address
161 First Street, Suite 2A/2B, MA 2142
Cambridge
United States
Email
Contact Number
+1 617 586 3100

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/foghorn-therapeutics” connections=”true” suffix=””]